Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada
A. Langer et al., Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada, CAN J CARD, 15(10), 1999, pp. 1095-1102
BACKGROUND: Significant differences are known to exist, between the United
States and Canada with respect to coronary catheterization and intervention
. In a post hoc analysis, it was hypothesized that these differences may ha
ve the greatest impact on outcome in patients at risk for recurrent events
such as those following myocardial infarction (MI).
PATIENTS AND METHODS: The hypothesis was tested in a nonrandomized comparis
on of the catheterization and revascularization patterns for patients follo
wing acute MI in 7029 patients in the United States and 1774 patients in Ca
nada who participated in the Coumadin/Aspirin Reinfarction Study (CARS). CA
RS tested the effectiveness of low dose warfarin in combination with acetyl
salicylic acid (ASA) Versus ASA alone in reducing cardiovascular morbidity
and mortality.
RESULTS: Before study enrolment (median day 7 to 8), 84.5% of the American
patients underwent coronary angiography compared with only 7.7% in Canada (
P<0.01). CARS patients in the United States underwent significantly more fr
equent angioplasty during their hospital admission before study enrolment t
han their Canadian counterparts (55.8% versus 3.0%, respectively, P<0.01),
and there was a more frequent use of intravenous heparin among American CAR
S patients (96% versus 88%, respectively, P<0.01) but less frequent adminis
tration of thrombolytic therapy (44% Versus 49%, respectively, P<0.01). For
follow-up of up to 32 months, American CARS patients had significantly few
er primary events (cardiovascular deaths, nonfatal MI, nonfatal ischemic st
roke) than Canadian patients. Cumulative estimate of a primary end point co
mparing American with Canadian patients was, respectively, 2.0% versus 3.1%
at one month, 8.0% versus 11.3% at one year and 11.6% versus 15.0% at two
years. Thus, time to the primary event was significantly longer in American
patients (P=0.0001). All-cause mortality estimates at 12 months were 2.2%
and 4.0%, respectively, for the American and Canadian CARS subgroups. When
management for the index MZ (ie, angiography and angioplasty) is included i
n the model, the risk of death for Canadian versus American subgroups of CA
RS is not statistically different (0.9, 95% CI 0.6 to 1.2, P=0.40).
CONCLUSION: Among study participants, American patients experienced a bette
r outcome than Canadian patients, which may be attributable to more aggress
ive management based on early coronary angiography and angioplasty. However
, angioplasty before study enrolment in American patients may have resulted
in enrolment of lower risk patients. This selection bias limits the scope
of the comparison.